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Abstract
Background: Genetic influences underpinning complex traits are thought to involve multiple
quantitative trait loci (QTLs) of small effect size. Detection of such QTL associations requires
systematic screening of large numbers of DNA markers within large sample populations. Using
pooled DNA on SNP microarrays to screen for allelic frequency differences between groups such
as cases and controls (called SNP Microarray and Pooling, or SNP-MaP) has been validated as an
efficient solution on both 10 k and 100 k platforms. We demonstrate that this approach can be
effectively applied to the truly genomewide Affymetrix GeneChip® Mapping 500 K Array.
Results: In comparisons between five independent DNA pools (N ~200 per pool) on separate
Affymetrix GeneChip® Mapping 500 K Array sets, we show that, for SNPs with minor allele
frequencies > 0.05, the reliability of the rank order of estimated allele frequencies, assessed as the
average correlation between allele frequency estimates across the DNA pools, was 0.948 (average
mean difference across the five pools = 0.069). Similarly, validity of the SNP-MaP approach was
demonstrated by a rank-order correlation of 0.937 (average mean difference = 0.095) between the
average DNA pool allele frequency estimates and the allele frequencies of an independent (CEPH)
sample of 60 unrelated individually genotyped subjects.
Conclusion: We conclude that SNP-MaP can be extended for use on the Affymetrix GeneChip®
Mapping 500 K Array, providing a cost-effective, reliable and valid initial screen of 500 K SNP
microarrays in genomewide association scans.
Background
The post-genomic era signals increased confidence in the
possibility of locating quantitative trait loci (QTLs) that
underpin the heritability of common complex disorders.
However, problems still remain and progress towards reli-
ably detecting QTLs for complex disorders, for which mul-
tiple genetic and environmental risk factors are
responsible, has been slower than expected [1]. Hypothe-
sis-driven candidate gene studies are important, but with
approximately 25,000 genes in the human genome it is
often difficult to predict how variation in gene product
will affect a particular phenotype. Moreover, it may be a
mistake to limit the search for QTLs to the 2% of the
genome that codes for proteins, rather than using a
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genomewide strategy that considers non-coding as well as
coding DNA sequences [2]. Linkage designs represent a
genomewide approach but are limited to detecting QTLs
of relatively large effect size [3,4]. Association designs are
needed to provide genomewide searches for QTLs of small
effect size but hundreds of thousands of DNA markers
genotyped on samples of thousands of individuals are
needed to detect QTLs of small effect size [5].
Microarrays that permit highly multiplexed genotyping
greatly reduce this genotyping burden. Several companies
have developed microarrays to meet the need for genom-
ewide association analysis (most notably Affymetrix™ and
Illumina™). In each case, single nucleotide polymor-
phisms (SNPs) are the marker of choice because they are
bi-allelic, abundant throughout the genome and relatively
stable from generation to generation [6]. Alleles of SNPs
close together on a chromosome will be correlated (that
is, in linkage disequilibrium) and thus they are also likely
to be associated with a QTL in between them, known as
indirect association [7,8].
The number of SNPs required for an indirect genomewide
association study depends on several factors, including
recombination frequencies, effect size, and sample
size[9]. It is estimated however, that approximately
500,000 'randomly chosen' SNPs or approximately
250,000 well-chosen 'tag SNPs', which take into account
patterns of linkage disequilibrium, are adequate to cap-
ture nearly all common variation in Caucasian, Han Chi-
nese, and Japanese populations [10,11].
With the advent of microarrays that genotype hundreds of
thousands of SNPs, genomewide association studies are
becoming a reality. For example, microarrays have been
instrumental in genomewide association scans that dis-
covered an intronic SNP in complement factor H (CFH)
causing age related macular degeneration [12], and a non
synonymous SNP in IL23R – a gene encoding a subunit of
a proinflammatory cytokine interleukin-23 receptor – that
confers susceptibility to Crohn's disease [13]. However,
these associations involve large effect sizes with odds
ratios greater than 3.0; very large samples will be needed
to detect smaller QTL effects.
The solution appears simple: Use microarrays to genotype
large cohorts for hundreds of thousands of SNPs. How-
ever, despite the high throughput of SNP genotyping
microarrays and the low cost per genotype, the cost of
individually genotyping a sample of even 1000 individu-
als remains prohibitive outside of large-scale consortia.
Until genotyping becomes even cheaper, one solution is
to screen the genome using DNA pools on microarrays to
nominate SNPs. DNA can be pooled for large samples of
cases and controls or the low and high extremes of a quan-
titative trait and the pooled DNA can be genotyped on
SNP microarrays, a method we call SNPMicroarrays and
DNA Pooling (SNP-MaP). The technique of DNA pooling
has been validated using both microsatellites [e.g., [14-
17]] and SNPs [e.g., [18-25]] on several genotyping plat-
forms, including the Affymetrix 10 K microarray [26-32],
100 K microarray [33], and one half of the two-chip 500
K microarray set [34]. The main advantage of DNA pool-
ing is that it provides average allele frequency estimates
for a group rather than genotyping each individual in the
group and then averaging their allele frequencies statisti-
cally. The main limitation is that individual genotypes
and haplotypes cannot be extracted because the DNA of
individuals is pooled.
The confirmation of previously identified associations
with rheumatoid arthritis have demonstrated the feasibil-
ity of SNP-MaP case-control study designs for detecting
susceptibility alleles to complex diseases [35]. Further-
more, substantive studies have already used pooled DNA
across a variety of microarray platforms to detect novel
SNP associations. SNP-MaP has been used as an initial
screen in the identification of four susceptibility loci for
mild mental impairment [36], 11 SNPs associated with
reading ability [37], and several SNPs, including an
intronic SNP from the diacylglycerol kinase eta (DGKH)
gene, associated with bipolar disorder [38]. These studies
were performed using Affymetrix 10 K, Affymetrix 100 K
and Illumina HumanHap550 microarrays, respectively.
Moreover, the Affymetrix GeneChip®  Mapping 500 K
Array set has already been used to allelotype DNA pools
in substantive research, implicating a KIBRA-encoding
locus in memory performance [39].
In this report we evaluate the applicability of DNA pools
on the first truly genomewide, commercially available
genotyping platform, the Affymetrix 500 K GeneChip®,
which affords significantly greater coverage of all com-
mon variation than do 10 K and 100 K arrays [10].
Although already employed in substantive research, three
subtle but potentially detrimental changes differentiating
the Affymetrix 500 K GeneChip® from its validated 10 K
and 100 K predecessors, deem validation of the full 500 K
set with pooled DNA desirable. These changes are: 1) the
introduction of two new restriction digest endonucleases,
NspI and StyI; 2) a decrease in feature size from 8 μm to 5
μm; and 3) a reduction from 40 to 24 probes per SNP for
90% of the 500 K microarray.
To ascertain the reliability and validity of genomewide
screening using DNA pools, we assayed five previously
validated, independent DNA pools (N ~200 independent
individuals per pool) separately on Affymetrix GeneChip®
Mapping 500 K Array sets. To assess reliability, the allele
frequency estimates were compared across the five DNABMC Genomics 2007, 8:214 http://www.biomedcentral.com/1471-2164/8/214
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pools. To assess validity, the average allele frequency esti-
mates across the five pools were compared with a CEPH
sample of 60 individuals from the HapMap project [11]
previously genotyped using the Affymetrix 500 K Gene-
Chip®.
Results
Detection rates
All five DNA pools produced similar detection rates with
the 500 K GeneChip®; rates varied from 87.9 to 97.5% for
the Sty array and 92.3 to 97.9% for the Nsp array. These
detection rates for the 500 K GeneChip® were similar to
those from our previous work using pooled DNA on the
10 K and 100 K GeneChip® platforms [29,32,33] and only
slightly less than for individual genotyping of the refer-
ence DNA sample provided by Affymetrix (99.3% for Sty,
98.9% for Nsp).
Allele frequency estimation
Rather than deriving separate RAS scores for sense and
anti-sense quartets, allele frequencies can be estimated
more reliably using a composite measure. Thus, allele fre-
quency estimates were calculated using a modified form
of the RAS score algorithm (RASav-all) based upon an aver-
age of all quartet measures.
Reliability
Reliability was assessed by correlating allele frequency
estimates across the five DNA pools using the Pearson cor-
relation coefficient (r), as well as calculating their average
absolute differences. As can be seen from Table 1, esti-
mates of allele frequency across the 500 K microarray are
highly reliable (N = 457,607 – 487,666 SNPs for which
70% of quartet measurements were available). The aver-
age correlation among the five DNA pools was 0.956 and
their average absolute difference was 0.066.
It is possible that these estimates of reliability are inflated
by the inclusion of low frequency alleles; particularly in
the case of non-polymorphic alleles when all SNPs are
considered. To control for this we re-ran these analyses
using only SNPs with MAF > .05 (N = 428,179 – 456,241
SNPs). Table 1 indicates similar results for correlations
(0.948) and mean differences (0.069).
Because we employ multiple biological replicates (con-
structed singly) without technical replicates it is difficult
to decompose variance attributable to microarray meas-
urement and pooling construction. However, a recent
paper using one microarray of the two-microarray Affyme-
trix 100 K set has estimated that the microarray compo-
nent of variance is up to seven times greater than that of
pool construction (variance due to microarray ≈ .00126
vs. variance due to pool construction ≈ .00018; [see [40]]).
Given the relationship between 500 K and 100 K perform-
ance (see below), we would expect to see similar estimates
of microarray variance for the 500 K microarray.
Validity
To assess validity, we compared our estimates of allele fre-
quencies from pooled DNA with individual genotyping
data from an independent sample of 60 CEPH individu-
als. All the CEPH individuals (as well as Han Chinese, Jap-
anese and Yoruban populations) have been genotyped for
SNPs on the Affymetrix 500 K microarray; these data,
which have been acquired using multiple genotyping plat-
forms, are available for download from the HapMap
project [11]. Considering the small CEPH sample size,
Table 2 indicates that the SNP-MaP approach exhibited
reasonable validity, reflected by high correlations (0.926
on average for both arrays) and modest mean differences
(0.100) between each pool and the CEPH population,
with similar results for MAF > .05. We found no difference
between array-type (Nspl or Styl) on indices of reliability
or validity, regardless of whether all SNPs or just common
SNPs (MAF > .05) were included.
As expected, validity was further improved when all five
DNA sub-pool estimates were aggregated, supporting the
use of multiple DNA sub-pools in SNP-MaP studies [33].
After excluding SNPs whose average minor allele fre-
quency across the five pools was less than .05 or which
had fewer than four pools, SNP-MaP estimates correlated
0.937 (mean difference = 0.095) with the CEPH popula-
tion (N = 412,626 SNPs). Standard errors of the mean
(SEM) across at least four replicates were small (approxi-
mately 60% of the data exhibited SEMs < 0.025 and 90%
of the data exhibited SEMs < 0.045) but were predictive of
validity, with smaller variance across replicates indicating
greater accuracy. We estimate that with at least 4–5 biolog-
ical replicate DNA pools, the SNP-MaP method has 80%
power to detect allele frequency differences between case
and controls on the order of .043 for rarer alleles (.05 <
MAF < .10) and .095 for common alleles (.45 < MAF < .5).
Artificial pooling experiment as an indication of reliability
After the removal of rare alleles (MAF < .05), the average
correlation between the allele frequencies of two simu-
lated biological replicate DNA pools – each containing
the individual genotypes of 30 unrelated individually gen-
otyped CEPH individuals – was calculated as 0.959. This
provides an expected correlation between two pools con-
taining independent samples and no technical variance
(microarray or pool construction). Although the differ-
ence between 0.959 and 0.948 (our observed estimates of
reliability) is small, with a p-value of 0.01 it is signifi-
cantly different, however; this significance should be
interpreted with caution as this is likely to reflect the sheer
immensity of SNPs correlated and does not act as a sum-BMC Genomics 2007, 8:214 http://www.biomedcentral.com/1471-2164/8/214
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mary statistic that can be used to quantify case-control
allele frequency differences across the microarray.
Reliability and validity of the 500 K GeneChip® versus 100 
K GeneChip®
Because the Affymetrix 500 K GeneChip® Mapping Array
shares 27,281 probe-sets with the 100 K GeneChip®, we
investigated how similar the two platforms performed
with the same DNA pools on the same SNPs. Overall, the
500 K platform performed slightly less well than the 100
K platform both in terms of reliability and validity. Using
RASav-all, indices of reliability (between DNA pool com-
parisons) for the 100 K microarray ranged from .958 to
.977 (mean = .967), whereas for the 500 K these correla-
tions ranged from .933 to .949 (mean .940). This trend
was mirrored in terms of validity when comparisons with
the CEPH population were considered (data not shown).
Discussion
The ability to screen common SNPs for allele frequency
differences with DNA pools is now feasible on a genom-
ewide scale using the Affymetrix 500 K GeneChip® Map-
ping Array. We allelotyped five previously validated DNA
pools on the 500 K microarray and show high reliability
and validity for more than 500,000 SNPs.
It is important to note that estimates of reliability and
validity, although high, were lower than those obtained
using the 10 K [36] and 100 K [33] platforms . Comparing
our previously published results for the 100 K platform
versus the present results for the 500 K platform, the aver-
age reliability correlation was 0.969 for the 100 K vs.
0.948 for the 100 K (average absolute difference: 0.054 vs.
0.069); the average validity correlation was 0.939 vs.
0.916 (average absolute difference: 0.081 vs. 0.104). A
reduction in both feature size and in the number of fea-
tures per SNP may be accountable for this decline in per-
formance from the 100 K array to the 500 K array.
Nonetheless, the performance of the 500 K array is ade-
quate, especially in comparison to the basic sampling var-
iation seen in our artificial pools using the individually
genotyped CEPH sample where no measurement error
was present. Concerns may arise with Affymetrix's latest
release, the SNP array 5.0, which sees all SNPs from the
two-chip 500 K set, along with 420,000 additional non-
polymorphic probes which may be used to assess copy
number variation, contained within a single microarray.
As our analysis currently employs mis-match probe data,
it remains to be seen if the reduction in the number of fea-
tures per SNP required for such multiplexing will further
reduce the reliability and validity of pooled DNA allele
frequency estimates.
Thus, we conclude that allele frequency estimates from
DNA pools appear reliable on the 500 K platform as well
as 100 K and 10 K platforms to screen for allele frequency
differences between groups. Despite the reliability and
validity found for pooled DNA, three limitations of this
Table 1: Reliability of allele frequency estimates in DNA pools for SNPs on the Affymetrix 500 K microarray.
Array All SNPs MAF > .05
Worst Best Average Worst Best Average
NspI (250 k) 0.952 (0.069) 0.969 (0.056) 0.957 (0.063) 0.934 (0.072) 0.963 (0.058) 0.947 (0.065)
StyI (250 k) 0.944 (0.075) 0.968 (0.067) 0.955 (0.070) 0.944 (0.079) 0.964 (0.070) 0.949 (0.073)
Both (500 K) 0.949 (0.071) 0.962 (0.062) 0.956 (0.066) 0.94 (0.075) 0.956 (0.065) 0.948 (0.069)
Values are mean Pearson correlation coefficients (r) between the 5 DNA pools using the average of all quartet estimates (RASav-all). 'Worst' and 
'Best' refer to the 10 bivariate comparisons between the 5 DNA pools and 'Average' is the average of these 10 correlations. Values in parentheses 
are mean absolute differences between DNA pools. 'All SNPs' includes all SNPs on the array (including rare and non-polymorphic SNPs) for which 
70% of quartet measurements were available (N = 457,607 – 487,666 across both microarrays). 'MAF > .05' only includes SNPs with minor allele 
frequency greater than .05 (N = 428,179 – 456,241 across both microarrays).
Table 2: Validity of allele frequency estimates in DNA pools for SNPs on the Affymetrix 500 K microarray.
Array All SNPs MAF > .05
Worst Best Average Worst Best Average
NspI (250 k) 0.913 (0.108) 0.942 (0.089) 0.928 (0.099) 0.902 (0.113) 0.935 (0.093) 0.918 (0.103)
StyI (250 k) 0.903 (0.114) 0.943 (0.089) 0.925 (0.101) 0.889 (0.119) 0.936 (0.093) 0.914 (0.106)
Both (500 K) 0.909 (0.111) 0.935 (0.094) 0.926 (0.100) 0.896 (0.116) 0.927 (0.098) 0.916 (0.104)
Values are average Pearson correlation coefficients (r) between the allele frequency estimates DNA pool and an independent population (CEPH) of 
60 individuals. 'Worst' and 'Best' refer to the 10 bivariate comparisons between the 5 DNA pools and 'Average' is the average of these 10 
correlations. Values in parentheses are mean absolute differences. 'All SNPs' includes all SNPs on the array including rare and non-polymorphic 
SNPs (N = 470,512 – 487,666). 'MAF > .05' only includes SNPs with minor allele frequency greater than .05 (N = 440,401 – 459,418).BMC Genomics 2007, 8:214 http://www.biomedcentral.com/1471-2164/8/214
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study should be mentioned, which put these results in an
even more favourable light. Firstly, in terms of validity,
these data are uncorrected for differential hybridisation
kinetics, which can result in unequal representations of
SNP alleles [27,31,33,41,42]. This is unimportant for
individual genotyping as allele-calling algorithms rou-
tinely process – and, in the case of homozygotes, actually
benefit from – discordant allele fluorescence values. If
DNA pooling is used to estimate absolute allele frequen-
cies, certain estimates will be biased when unequal allelic
representation occurs. However, DNA pooling is rarely
used to estimate absolute allelic frequencies. DNA pool-
ing is usually used to assess relative differences between
groups such as cases and control; previous reports of dif-
ferential hybridisation [27] indicating that the proportion
of SNPs exhibiting differential hybridisation (likely to
result in type I and type II errors) is small, suggests all
pools are subject to similar technical variation and thus
allelic bias. A suitable next step however, is to identify the
specific SNPs that exhibit large differential hybridisation
and either omit these from subsequent analysis or correct
in the appropriate manner [e.g., k correction; see [42,43]].
Secondly, the CEPH population that we used to deter-
mine validity is a relatively small sample, which will have
undoubtedly reduced estimates of validity. Thirdly, relia-
bility was assessed as the average difference between just
one pool and another, rather than the difference between
groups using multiple sub-pools for each group. It is
therefore likely that our estimates of reliability are con-
servative underestimates, as may be inferred by the distri-
bution of small SEMs.
DNA pooling involves several limitations. With DNA
pooling it is not possible to extract individual genotypic
information to allow analyses of individual differences or
haplotypes. In addition, once individuals have been
pooled they cannot be 'unpooled', thus tethering tests of
allele frequency differences to the phenotype used for
pooling [44]. However, these issues are offset by the con-
siderable financial benefits of DNA pooling.
As with individual genotyping, issues of multiple testing
and false positive results are critical for genomewide asso-
ciation analyses using SNP microarray. As one might
expect, replication has been demonstrated to improve
estimates of allele frequency, and therefore may be used to
reduce, although by no means eliminate, the dilemma
posed by false positive results [45]. Although no consen-
sus has yet been reached as to the fairest method of ana-
lysing the enormous volume of data generated by
genome-wide studies, especially for identifying QTLs of
small effect size, progress with regard to high-throughput
microarrays is being made [46]. Regardless of which sta-
tistical procedures are agreed upon that demonstrate ade-
quate association, the ultimate criterion for association
must be independent replication. The expense of individ-
ually genotyping large samples using SNP arrays makes
replication of genomewide association scans unlikely.
However, because DNA pooling is relatively inexpensive,
SNP-MaP strategies will facilitate replication on a genom-
ewide scale.
Conclusion
With results for reliability and validity similar to those
previously demonstrated on 10 k and 100 k arrays, we
have shown that the SNP-MaP approach can be applied to
a 500 k platform. We conclude that the Affymetrix 500 K
GeneChip® Mapping Array can be used in SNP-MaP stud-
ies to provide an efficient, reliable, and valid genomewide
screen of allele frequency differences between groups,
thus facilitating the detection of SNPs of small effect size.
Methods
Samples
Five independent pools of DNA were created from a sam-
ple of 1028 white Caucasian individuals (538 females and
490 males) randomly selected from a representative com-
munity-based sample of more than 14,000 children in the
Twins Early Development Study, which we used in a SNP-
MaP study of cognitive ability and disability with the 10 K
microarray [36].
DNA quantification and pool construction
DNA samples were extracted from buccal swabs [47],
quantified using a spectrophotometer (260 nm) and
diluted to a target concentration of 50 ng/μl. Each sample
was subsequently quantified in triplicate using fluorime-
try (employing PicoGreen® dsDNA quantitation reagent,
Cambridge Bioscience, UK) and samples that were accu-
rately quantified (± 0.5 ng/μl) were accepted for pooling.
Each individual's DNA was randomly assigned to one of
five DNA pools, thus providing five independent pools
with 204–206 individuals. Each individual contributed
79.1 ng of DNA to a DNA pool. Each pool concentration
ranged from 13.33 to 13.57 ng/μl.
SNP microarray allelotyping of pooled DNA
Because pooled DNA can be used only to estimate allelic
frequency, not genotypic frequency, we refer to allelotyp-
ing rather than genotyping. Each of the five DNA pools
was allelotyped using the GeneChip®  Mapping 500 K
Array set in accordance with the standard protocol for
individual DNA samples (see the GeneChip® Mapping
500 K Assay Manual for full protocol). Each microarray
was scanned using the GeneChip® Scanner 3000 with
High-Resolution Scanning Upgrade, which was control-
led using GeneChip® Operating software (GCOS) v1.4.
Cell intensity (.cel) files were analyzed using GTYPE. Each
of the five DNA pools was assayed on a separate microar-BMC Genomics 2007, 8:214 http://www.biomedcentral.com/1471-2164/8/214
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ray set; for quality control checks, a reference DNA indi-
vidual provided by the manufacturer (sample number
100103) was also assayed on a separate microarray set.
Generation of SNP-MaP allele frequency estimates
Relative Allele Signal (RAS) scores, calculated using the 10
K MPAM Mapping algorithm, have been shown to be reli-
able and valid indices of allele frequency in pooled DNA
[26-32]. Provided by Affymetrix, the GTYPE user's manual
contains a full description of the Affymetrix Mapping
GeneChip® probe-sets and how they are used to calculate
RAS scores. Briefly, a RAS score for each SNP is derived
from multiple 'quartet' measures. Quartets contain four
25 bp sequences (probes) with variations on the central
base. The central base of the probe-set corresponds to two
perfect match (PM) probes and two mismatch (MM)
probes for each allele of the SNP, allele A (PMA and MMA)
and allele B (PMB  and  MMB). There is a 90:10 split
between 6 and 10 quartet measures per SNP on the 500 K
microarray set. These quartets occur either exclusively on
the sense or anti-sense strand, or on both strands. The dis-
tribution of quartets relative to the SNP site varies from
SNP to SNP but can include up to seven quartets up or
downstream of the SNP site ('off-sets') including the SNP
site itself ('zero offset') on a single strand. After subtract-
ing the average mismatch intensity ( ) from each PM
probe, a RAS score for each quartet is generated by calcu-
lating the ratio of A to A+B fluorescence values. If   >
PMA OR   >  PMB, PM fluorescence values for that allele
are set to 0. In such instances ratios produce monomor-
phic RAS scores. If   > PMA AND   >  PMB, no inter-
pretable signal is obtained (because the denominator is
0). In such instances the quartet was not used in subse-
quent analyses. Only SNPs that retained at least 70% of
their available quartets were used in subsequent analyses
(i.e., 5/6 or 7/10 quartets). Approximately 96% of SNPs
are retained using this criterion, depending on the suc-
cessfulness of the assay.
Allele frequency estimates for the 500 K microarray set
were calculated manually from the raw probe intensity
data exported as a .txt file, for reasons outlined previously
[33]. In this study, however, we used a modified version
of the RAS score algorithm that is based on an average of
all quartet measures (RASav-all) rather than deriving sepa-
rate RAS scores for sense and anti-sense quartets. The
rationale for using RASav-all was twofold: Sense and anti-
sense measures should not differ systematically and a
composite measure should be more reliable.
Analysis
Reliability was assessed in relation to the average correla-
tion between the 5 DNA pools across all SNPs. Validity
was assessed by comparing average allele frequency esti-
mates across 5 DNA pools to those from the independent
sample available from HapMap [11] and NetAffx™ [48].
The sample included 60 unrelated individuals from CEPH
trios (30 mothers and 30 fathers) who were genotyped
using the Affymetrix 500 K GeneChip® for the HapMap
project [11].
Artificially constructed pooling experiment
To evaluate the level at which the observed SNP-MaP
inter-chip reliability might compare to an ideal individual
genotyping scenario, a simulated pooling experiment
involving unrelated individuals was conducted using the
genotypes of CEPH parents deposited in HapMap. Two
independent pools were constructed: one comprising 30
CEPH mothers, the other 30 CEPH fathers. The allele fre-
quencies of the pools were calculated separately and then
correlated with each other using SPSS.
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